Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$22.67 - $35.0 $75 Million - $116 Million
-3,309,206 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$26.93 - $34.7 $25.3 Million - $32.6 Million
938,910 Added 39.61%
3,309,206 $110 Million
Q4 2018

Feb 14, 2019

BUY
$27.23 - $45.56 $19.7 Million - $33 Million
723,966 Added 43.97%
2,370,296 $68.9 Million
Q3 2018

Nov 14, 2018

BUY
$37.57 - $50.34 $61.9 Million - $82.9 Million
1,646,330 New
1,646,330 $75.7 Million
Q4 2017

Feb 14, 2018

SELL
$28.45 - $37.14 $56.1 Million - $73.3 Million
-1,973,177 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$24.01 - $36.2 $47.4 Million - $71.4 Million
1,973,177
1,973,177 $71.4 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.1B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.